Document is current
Any future updates will be listed below
-
Authors
Sunagawa, Genya
Saku, Keita
Arimura, Takahiro
Nishikawa, Takuya
Mannoji, Hiroshi
Kamada, Kazuhiro
Abe, Kiyokazu
Kishi, Takuya
Tsutsui, Hiroyuki
Sunagawa, Kenji
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (Research and development of supportive device technology for medicine using ICT, Development of Advanced Measurement and Analysis Systems)
- License Information
-
More Information
Article History
Received: 31 January 2018
Accepted: 27 April 2018
First Online: 7 May 2018
Compliance with Ethical Standards
:
: K. Sunagawa works in a department endowed by Omron Healthcare Co. and Actelion Pharmaceuticals, Japan, and has received research resources (Impella console and Impella CP® catheters) from Abiomed Inc. K. Saku and T. Kishi work in a department endowed by Omron Healthcare Co. G. Sunagawa, T. Arimura, T. Nishikawa, H. Mannoji, K. Kamada, and K. Abe have nothing to declare. H. Tsutsui received honoraria from Daiichi Sankyo, Inc., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, Boehringer Ingelheim Japan, Inc., Novartis Pharma K.K., Bayer Yakuhin, Ltd., Bristol-Myers Squibb KK, and Astellas Pharma Inc. and research funding from Actelion Pharmaceuticals Japan, Daiichi Sankyo, Inc. and Astellas Pharma Inc.
: No human studies were carried out by the authors for this article.
